Women with known BRCA1/2 mutations are strongly recommended to consider a RRSO from their early 40 s in order to reduce their increased risk of fallopian tube, ovarian and breast carcinoma [7,10]. The gene discussed is BRCA1; the disease is breast carcinoma.